Jamey Mock, Moderna CFO
Updated: Moderna reports $238M manufacturing write-down as cuts, new vaccines shape 2025
Moderna is working on restoring investors’ faith that its Covid-19 vaccine was not a one-hit-wonder. It also has to show it can get its costs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
